在固体瘤中Sacituzumab govitecan的有效性和安全性:系统性审查和元分析

Yaping Zhang1, Jian Chen2, Xiaoyan Wang1

  • 1Department of Oncology, Affliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, China.

PubMed
概括

萨西图祖马布 (Sacituzumab) 改善了固体瘤的整体存活率和无进展存活率,但增加了中性衰竭和腹的风险. 它在乳腺癌和泌尿器癌中显示出更大的益处.